Literature DB >> 23271025

Polymorphisms in human DNA repair genes and head and neck squamous cell carcinoma.

Rim Khlifi1, Ahmed Rebai, Amel Hamza-Chaffai.   

Abstract

Genetic polymorphisms in some DNA repair proteins are associated with a number of malignant transformations like head and neck squamous cell carcinoma (HNSCC). Xeroderma pigmentosum group D (XPD) and X-ray repair cross-complementing proteins 1 (XRCC1) and 3 (XRCC3) genes are involved in DNA repair and were found to be associated with HNSCC in numerous studies. To establish our overall understanding of possible relationships between DNA repair gene polymorphisms and development of HNSCC, we surveyed the literature on epidemiological studies that assessed potential associations with HNSCC risk in terms of gene-environment interactions, genotype-induced functional defects in enzyme activity and/or protein expression, and the influence of ethnic origin on these associations.We conclude that large, well-designed studies of common polymorphisms in DNA repair genes are needed. Such studies may benefit from analysis of multiple genes or polymorphisms and from the consideration of relevant exposures that may influence the likelihood of HNSCC when DNA repair capacity is reduced.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23271025     DOI: 10.1007/s12041-012-0193-z

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  81 in total

Review 1.  How nucleotide excision repair protects against cancer.

Authors:  E C Friedberg
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

2.  Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck.

Authors:  E M Sturgis; E J Castillo; L Li; R Zheng; S A Eicher; G L Clayman; S S Strom; M R Spitz; Q Wei
Journal:  Carcinogenesis       Date:  1999-11       Impact factor: 4.944

3.  XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries.

Authors:  Nadia Laantri; Majida Jalbout; Meriem Khyatti; Wided Ben Ayoub; Sami Dahmoul; Messaoud Ayad; Wided Bedadra; Meriem Abdoun; Sarah Mesli; Mostafa Kandil; Mokhtar Hamdi-Cherif; Kada Boualga; Noureddine Bouaouina; Lotfi Chouchane; Abdellatif Benider; Farhat Ben-Ayed; David Goldgar; Marilys Corbex
Journal:  Mol Carcinog       Date:  2011-04-22       Impact factor: 4.784

4.  Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.

Authors:  Volker Harth; Martin Schafer; Josef Abel; Laura Maintz; Thomas Neuhaus; Mette Besuden; Robert Primke; Anja Wilkesmann; Ricarda Thier; Hans Vetter; Yon-Dschun Ko; Thomas Bruning; Hermann M Bolt; Katja Ickstadt
Journal:  J Toxicol Environ Health A       Date:  2008

5.  Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK.

Authors:  Alessandra A Affatato; Kevin J Wolfe; Mirtha S Lopez; Csilla Hallberg; Marinel M Ammenheuser; Sherif Z Abdel-Rahman
Journal:  Environ Mol Mutagen       Date:  2004       Impact factor: 3.216

6.  Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.

Authors:  Joke Werbrouck; Kim De Ruyck; Fréderic Duprez; Marc Van Eijkeren; Ernst Rietzschel; Sofie Bekaert; Anne Vral; Wilfried De Neve; Hubert Thierens
Journal:  Mutat Res       Date:  2008-08-13       Impact factor: 2.433

7.  A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis.

Authors:  Hongbing Shen; Erich M Sturgis; Kristina R Dahlstrom; Yuxin Zheng; Margaret R Spitz; Qingyi Wei
Journal:  Int J Cancer       Date:  2002-06-20       Impact factor: 7.396

8.  [Association of the XRCC1 and hOGG1 polymorphisms with the risk of laryngeal carcinoma].

Authors:  Yuan Yang; He Tian; Zhi-jun Zhang
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2008-04

9.  Influence of XRCC1 Genetic Polymorphisms on Ionizing Radiation-Induced DNA Damage and Repair.

Authors:  Silvia Sterpone; Renata Cozzi
Journal:  J Nucleic Acids       Date:  2010-07-25

10.  Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to Squamous Cell Carcinomas of the Head and Neck (SCCHN) and Breast cancer in the north Indian population.

Authors:  Amit Kumar Mitra; Neetu Singh; Vivek Kumar Garg; Rashmi Chaturvedi; Mandira Sharma; Srikanta Kumar Rath
Journal:  J Exp Clin Cancer Res       Date:  2009-07-18
View more
  5 in total

Review 1.  Photosensitive human syndromes.

Authors:  Graciela Spivak; Philip C Hanawalt
Journal:  Mutat Res       Date:  2014-11-14       Impact factor: 2.433

2.  Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis.

Authors:  Yadong Wang; Xinwei Chu; Xiaojing Meng; Fei Zou
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

3.  Common polymorphisms of the hOGG1, APE1 and XRCC1 genes correlate with the susceptibility and clinicopathological features of primary angle-closure glaucoma.

Authors:  Kun Zeng; Bo Zhong; Min Fang; Xiao-Li Shen; Li-Na Huang
Journal:  Biosci Rep       Date:  2017-05-17       Impact factor: 3.840

4.  DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects.

Authors:  Yin Lou; Wen-jia Peng; Dong-sheng Cao; Juan Xie; Hong-hong Li; Zheng-xuan Jiang
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

5.  XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma.

Authors:  Jingjing Cheng; Weiran Liu; Xianliang Zeng; Bin Zhang; Yihang Guo; Minghan Qiu; Chao Jiang; Huanhuan Wang; Zhiqiang Wu; Maobin Meng; Hongqing Zhuang; Lujun Zhao; Jihui Hao; Qingqing Cai; Dan Xie; Qingsong Pang; Ping Wang; Zhiyong Yuan; Dong Qian
Journal:  Cancer Sci       Date:  2015-11-06       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.